0001606498-23-000035.txt : 20230323 0001606498-23-000035.hdr.sgml : 20230323 20230323113104 ACCESSION NUMBER: 0001606498-23-000035 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230306 FILED AS OF DATE: 20230323 DATE AS OF CHANGE: 20230323 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greiner Michael CENTRAL INDEX KEY: 0001520392 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36440 FILM NUMBER: 23755020 MAIL ADDRESS: STREET 1: C/O VISTAPRINT STREET 2: 95 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVANOS MEDICAL, INC. CENTRAL INDEX KEY: 0001606498 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 464987888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5405 WINDWARD PARKWAY STREET 2: SUITE 100 SOUTH CITY: ALPHARETTA STATE: GA ZIP: 30004 BUSINESS PHONE: 844-428-2667 MAIL ADDRESS: STREET 1: 5405 WINDWARD PARKWAY STREET 2: SUITE 100 SOUTH CITY: ALPHARETTA STATE: GA ZIP: 30004 FORMER COMPANY: FORMER CONFORMED NAME: Avanos Medical, Inc. DATE OF NAME CHANGE: 20180702 FORMER COMPANY: FORMER CONFORMED NAME: Halyard Health, Inc. DATE OF NAME CHANGE: 20140424 4/A 1 wf-form4a_167958545286655.xml FORM 4/A X0407 4/A 2023-03-06 2023-03-07 0 0001606498 AVANOS MEDICAL, INC. AVNS 0001520392 Greiner Michael 5405 WINDWARD PKWY ALPHARETTA GA 30004 0 1 0 0 SVP - Chief Financial Officer 0 Common Stock 2023-03-06 4 A 0 34619 0 A 129050 D Common Stock 2023-03-06 4 F 0 3037 29.62 D 126013 D Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 6, 2024, 1/3 on March 6, 2025 and 1/3 on March 6, 2026. Total beneficially owned includes 339 shares acquired on December 30, 2022 and 327 shares acquired on June 30, 2022 under the Issuer's Employee Stock Purchase Plan. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on March 4, 2022, 1/3 of which vested on March 4, 2023, with the remainder vesting 1/3 on March 4, 2024 and 1/3 on March 4, 2025. This Form 4/A is being filed to correct an error in the calculation of the number of time-based restricted share units issued to the Reporting Person on March 6, 2023 pursuant to the Issuer's 2021 Long Term Incentive Plan. /s/ Mojirade James, as attorney-in-fact for Michael C. Greiner 2023-03-23